Daily Chart

Novartis Ag-adr (NVS) Financial News - Novartis net profit rises 12% on sales gain of 27%

Novartis Ag-adr (NVS)

Novartis net profit rises 12% on sales gain of 27%

Keywords: , NVS, Novartis AG ADS, NOVN, Novartis AG
Quote: MADRID (MarketWatch) -- Swiss pharmaceutical group Novartis AG/quotes/zigman/171707/quotes/nls/nvsNVS-1.17%/quotes/zigman/278066CH:NOVN+3.46%on Tuesday announced second-quarter net attributable profit of $2.7 billion, against profit of $2.42 billion in the same period a year ago. Net sales rose 27% to $14.92 billion against $11.72 billion. A survey of analysts polled by Dow Jones Newswires was forecasting second-quarter net profit of $3.04 billion on sales of $14.49 billion. Novartis said sales were boosted 8% by a weaker dollar, while recently launched products grew 46% over the prior year-year, boosting sales by $3.8 billion. Group constant currency sales growth is expected to be around the double-digit mark, based on consolidation of Alcon for four months in 2010. Pharmaceuticals sales are expected to grow in the low-to mid-single digits, with volume growth more than offsetting the impact of generic competition. Alcon sales are expected to increase at a mid-to high-single digit rate, pro forma. Novartis said if June average exchange rates prevail for the rest of the year, the impact will likely have a 5% positive effect on sales and 3% negative effect on operating income for the full year....
Open whole article (external link)

Other Financial and Stock Market News concerning Novartis Ag-adr

Novartis Ag-adr Stock Summary

Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2011-2012.